de Jongh, Jerney
Verweij, Nicki J. F.
Yaqub, Maqsood
van Denderen, Christiaan J.
van der Horst-Bruinsma, Irene E.
Bot, Joost C. J.
Boden, Bouke J. H.
Hemke, Robert
Smithuis, Frank F.
Lems, Willem F.
Lammertsma, Adriaan A.
Voskuyl, Alexandre E.
Boers, Maarten
Zwezerijnen, Gerben J. C.
van der Laken, Conny J.
Article History
Received: 21 July 2022
Accepted: 4 December 2022
First Online: 12 December 2022
Declarations
:
: This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Approval was granted by the Ethics Committee of the VU University Medical Center (2013/38).
: All patients gave written informed consent to participate in the study.
: Not applicable.
: J.d.J., N.J.F.V., M.Y., C.J.v.D. J.C.J.B., B.J.H.B., R.H., F.F.S., A.A.L., A.E.V., M.B., G.J.C.Z., C.J.v.d.L.: no competing interests to declare.I.E.v.d.H.B: consultant for AbbVie, UCB, MSD, Novartis, Lilly; unrestricted grants received for investigator-initiated studies from MSD, Pfizer, AbbVie, UCB; fees received for Lectures from BMS, AbbVie, Pfizer, MSD, UCB. W.F.L.: speaker fees/advisory boards for Pfizer. Amgen, UCB, Galapagos.